SDRC PILOT AND FEASIBILITY AWARDS
2019 Pilot and Feasibility Awards
Based on our recent Pilot and Feasibility request for applications, we received 18 project proposals. The Stanford Diabetes Research Center is committed to providing support for the most innovative and unique research proposals related to diabetes in all disciplines. Our goal is to support, enhance and foster new ideas that will improve how we understand, diagnose, treat and care for diabetes and its complications. The P&F program is a SDRC hallmark designed to meet this goal.
Thank you to all applicants for their submissions, and congratulations again to this year's awardees!
Eric Appel PhD | Assistant Professor, Material Science and Engineering
“Expanding Global Access to Insulin by Eradicating the Cold Chain”
Mark Davis, PhD | Burt and Marion Avery Family Professor, Microbiology and Immunology
“Targeting KIR+ Regulatory CD8+ T cells in Type 1 Diabetes”
Laya Ekhlaspour, MD | Instructor, Pediatrics
Collaborators: Bruce Buckingham MD, Manisha Desai PhD
“Modeling and modulating insulin delivery in automated insulin delivery systems to accommodate for meal compositions”
Garry Fathman, MD | Professor, Department of Medicine (Immunology and Rheumatology)
Collaborator: Darrell Wilson MD
“Changes in FCGR2B expression during the pathogenesis and progression of type 1 diabetes”
Peter Jackson, PhD | Professor, Microbiology and Immunology
Collaborator: Seung Kim MD PhD
“Identification and target validation of ciliary GPCRs directing pancreatic β-cell proliferation and GSIS”
James Priest, MD | Assistant Professor, Pediatrics
“Dissecting mechanisms of maternal diabetic risk for congenital heart disease in offspring”
Avnesh Thakor, MD PhD | Assistant Professor, Radiology
“Facilitating pancreatic islet survival and function following transplantation using mesenchymal stem cells”
The 2019 Pilot and Feasibility Program has been generously co-sponsored by the Maternal and Child Health Research Institute and the Department of Pediatrics
Fredric B. Kraemer, M.D. received his Bachelor's degree in Chemistry from Emory University in 1970 and his M.D. from New York University in 1974. He was a house officer in Internal Medicine at Kings County/Downstate Medical Center (1974-1978) and a postdoctoral fellow in Endocrinology at Stanford University (1978-1982). He joined the faculty in the Department of Medicine at Stanford in 1983, with an appointment at the Palo Alto VA Hospital in 1988. Dr. Kraemer currently holds the Stanford University Professorship in Endocinology and is the Chief of the Divison of Endocrinology, Gerontology and Metabolism, as well as a staff physician at the VA Palo Alto Health Care System. He was Associate Chief of Staff for Research and Development at the VA Palo Alto Health Care System from 2002-2007. His clinical and research interests have been focused on diabetes and cellular lipid metabolism. Dr. Kraemer's research program has been supported throughout his career by grants from the NIH and the Department of Veterans Affairs. He has won several awards including a Special Emphasis Research Career Award from the NIH, a SmithKline Beecham Junior Faculty Award in Diabetes, and an Arteriosclerosis Special Recognition Award from the Council on Arteriosclerosis, Thrombosis and Vascular Biology of the American Heart Association. Dr. Kraemer has served as president of the Western States Affiliate of the American Hearth Association, on the Scientific Advisory Committee of the University of California Tobacco-Related Disease Program, and the University of Minnesota Obesity Center, and the Advisory Board of the Deuel Conference on Lipids. In addition, he has served on a number of grant review boards for VA, NIH, American Diabetes Association and American Heart Association.